The Determination of Genetic Basis Of Immunodeficiency

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID). Patients with immunodeficiencies may be eligible for this study. Candidates include: * Patients with diminished numbers of T cells or NK cells or both, or * Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function. Relatives of patients will also be studied. Participants will have blood samples collected for genetic analysis in studies related to SCID at the National Institutes of Health and other institutions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 99
Healthy Volunteers: f
View:

⁃ Index cases to be included are those with diminished numbers of T cells and/or NK cells and/or B cells or other immune cells or those who have normal numbers of T cell, B cells, NK cells and other immune cells but diminished function of one or more immune cells. Relatives of affected individuals may also be studied

• Patients (index cases): 6 months of age and older

• Siblings: 6 months of age and older

• Non-sibling relatives (biological parent, aunt, uncle or grandparent): 18 years or older

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Warren J Leonard, M.D.
wl2w@nih.gov
(301) 496-0098
Time Frame
Start Date: 2004-04-05
Participants
Target number of participants: 100
Treatments
Non-sibling relative
18 years of age or older
Patients (index cases)
Patients (index cases), 6 months of age or older
Siblings
Siblings, 6 months of age or older
Sponsors
Leads: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials